Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Melanoma: HELP
Helen Schmid
Based on 13 articles published since 2010
(Why 13 articles?)
||||
Expertise Level
The expertise of Helen Schmid ranks in the
  • Top 3.6%
  • ... of 119,511 published authors worldwide on Melanoma
  • ... from 2010 through 2020
  • ... based on contributions to 13 articles on the topic.
Graphical view (beta)
Work Locations
Details
Most likely:    University of Sydney      
2019
  • Department of Epidemiology and Biostatistics, Texas A&M University, College Station, Texas. · Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania, Philadelphia, Pennsylvania. · Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida. · Assistance Publique-Hôpitaux de Paris, Hôpital Cochin et Université Paris Descartes, Paris, France. · Section of Epidemiology and Biostatistics, Leeds Institute of Medical Research at St. James's, University of Leeds, Leeds, United Kingdom. · Gustave Roussy, Université Paris-Saclay, Département de Biopathologie and Institut National de la Santé et de la Recherche Médicale U1186, Villejuif, France. · Department of Internal Medicine and Medical Specialties, University of Genoa and Istituto de Ricovero e Cura a Carattere Scientifico AOU San Martino-IST, Genoa, Italy. · Dermatology Unit, Maurizio Bufalini Hospital, Cesena, Italy. · Melanoma Unit, Dermatology Department, Hospital Clinic Barcelona, Institut de Investigacions Biomediques August Pi Sunyer, Universitat de Barcelona, Barcelona, Spain. · Sydney School of Public Health, The University of Sydney, Sydney, Australia; Melanoma Institute Australia, The University of Sydney, Sydney, Australia. · Institut National de la Santé et de la Recherche Médicale UMR-946, Genetic Variation and Human Disease Unit, Université Paris Diderot, Paris, France. · Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania. · Department of Clinical Genetics, University Hospital of Copenhagen, Copenhagen, Denmark. · Human Genetics Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland. · Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, Brazil. · Department of Dermatology, Leiden University Medical Centre, Leiden, the Netherlands. · Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden. · QIMR Berghofer Medical Research Institute, Herston, Australia. · Institute of Oncology Ljubljana, Zaloska, Ljubljana, Slovenia. · Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Westmead Institute for Medical Research, University of Sydney, Sydney, Australia. · Department of Clinical Sciences, Lund University Hospital Lund, Sweden; Department of Surgery, Lund University Hospital, Lund, Sweden. · Department of Pathology, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, Brazil. · Unidad de Lesiones Pigmentadas, Cátedra de Dermatología, Hospital de Clínicas, Universidad de la República, Montevideo, Uruguay. · Department of Dermatology, Instituto Valenciano de Oncologia, Valencia, Spain. · Latvian Biomedical Research and Study Centre, Riga, Latvia. · Melanoma Unit, Dermatology Department, Hospital Clinic Barcelona, Institut de Investigacions Biomediques August Pi Sunyer, Universitat de Barcelona, Barcelona, Spain; Centro de Investigacion Biomedica en Red de Enfermedades Raras, Instituto de Salud Carlos III, Barcelona, Spain. · Department of Clinical Genetics, Leiden University Medical Center Leiden, the Netherlands. · Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida. Electronic address: · Pubmed 30731170
2018
  • Cancer Epidemiology and Prevention Research, Sydney School of Public Health, The University of Sydney, Camperdown, New South Wales, Australia. · Melanoma Institute Australia, Sydney, New South Wales, Australia. · Now with The Kirby Institute, University of New South Wales, Sydney, Australia. · Faculty of Medicine and Health, Sydney School of Public Health, The University of Sydney, Sydney, New South Wales, Australia. · Melanoma Research Group, Centre for Cancer Research, The Westmead Institute for Medical Research, The University of Sydney, Sydney, New South Wales, Australia. · The School of Population Health, The University of Western Australia, Perth, Australia. · Viertel Cancer Research Centre, Cancer Council Queensland, Brisbane, Australia. · Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia. · Cancer Epidemiology and Intelligence Division, Cancer Council Victoria, Melbourne, Australia. · Pubmed 30027280
2016
  • Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, USA. · Department of Biostatistics and Bioinformatics, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA. · Department of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, Pennsylvania, USA. · Assistance Publique-Hôpitaux de Paris, Hôpital Cochin et Université Paris Descartes, Paris, France. · Department of Dermatology, Sheba Medical Center, Tel Hashomer, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. · Department of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands. · Department of Internal Medicine and Medical Specialties, University of Genoa and IRCCS AOU San Martino-IST Genoa, Italy. · Section of Epidemiology and Biostatistics, Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK. · Department of Biopathology and INSERM U1186, Gustave Roussy, Villejuif, France. · Dermatology Unit, Maurizio Bufalini Hospital, Cesena, Italy. · Division of Genetic Epidemiology, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, Utah, USA. · Melanoma Unit, Dermatology Department, Hospital Clinic, IDIBAPS, Barcelona, Spain and CIBER de Enfermedades Raras, Barcelona, Spain. · Sydney School of Public Health, University of Sydney, Sydney, NSW, Australia. · INSERM, UMR-946, Genetic Variation and Human Disease Unit, Université Paris Diderot, Paris, France. · Departments of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA. · The Susanne Levy Gertner Oncogenetics Unit, The Danek Gertner Institute of Human Genetics, Chaim Sheba Medical Center, Tel-Hashomer, Israel. · Department of Clinical Genetics, University Hospital of Copenhagen, Copenhagen, Denmark. · Human Genetics Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA. · Universidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre RS, Brazil. · Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden. · QIMR Berghofer Medical Research Institute, Herston, QLD, Australia. · Institute of Oncology Ljubljana, Zaloska, Ljubljana, Slovenia. · Centre for Cancer Research, Westmead Institute for Medical Research and Melanoma Institute Australia, University of Sydney, NSW, Australia. · Department of Surgery, Lund University Hospital, Lund, Sweden. · Department of Pathology, Escola Paulista de Medicina, UNIFESP, São Paulo, Brazil. · Unidad de Lesiones Pigmentadas, Cátedra de Dermatología, Hospital de Clínicas, Universidad de la República, Montevideo, Uruguay. · Oregon Health Sciences University School of Medicine, Department of Dermatology, Portland, Oregon, USA. · Department of Dermatology, Instituto Valenciano de Oncologia, Valencia, Spain. · Latvian Biomedical Research and Study Centre, Riga, Latvia. · Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, USA. Electronic address: · Pubmed 26827760
2014
  • Section of Epidemiology and Biostatistics, Leeds Institute of Cancer and Pathology (LICAP), University of Leeds, Leeds, UK. · Cancer Epidemiology and Services Research (CESR), Sydney School of Public Health, Sydney Medical School, The University of Sydney, Sydney, Australia. · Dermatology Department and Biochemistry and Molecular Genetics Department, Melanoma Unit, Hospital Clinic, Instituto de Investigaciones Biomédicas August Pi I Sunyer (IDIBAPS), Barcelona, Spain ; Centro Investigación Biomédica en Enfermedades Raras (CIBERER), Instituto de Salud Carlos III (ISCIII), Barcelona, Spain. · Westmead Institute for Cancer Research and Melanoma Institute, Australia, University of Sydney at Westmead Millennium Institute, Sydney, Australia. · Viertel Centre for Research in Cancer Control, The Cancer Council Queensland, Spring Hill, Brisbane, Australia. · Centre for Epidemiology & Biostatistics, School of Population Health, University of Melbourne, Melbourne, Australia ; Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Australia. · Centre for Epidemiology & Biostatistics, School of Population Health, University of Melbourne, Melbourne, Australia. · Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL USA. · Genomics Facility, Leeds Cancer Research UK Centre, University of Leeds, Leeds, UK. · Dermatology Department and Biochemistry and Molecular Genetics Department, Melanoma Unit, Hospital Clinic, Instituto de Investigaciones Biomédicas August Pi I Sunyer (IDIBAPS), Barcelona, Spain. · Medicina Laboral, Lafarge Cementos y Finanzauto, S.A., Barcelona, Spain. · Pubmed 25780468
  • Discipline of Dermatology, University of Sydney at the Sydney Cancer Centre, Sydney, New South Wales, Australia2Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia3Sydney Melanoma Diagnostic Centre, Sydney Cancer Centre, Sydney, New South. · Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia3Sydney Melanoma Diagnostic Centre, Sydney Cancer Centre, Sydney, New South Wales, Australia. · National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney, New South Wales, Australia. · Raudonikis Database Services, Mount Colah, New South Wales, Australia. · University of Sydney at the Westmead Millennium Institute, Westmead, New South Wales, Australia9Melanoma Institute Australia, Westmead, New South Wales, Australia. · Pubmed 24964862
2015
  • Affiliations of authors: QIMR Berghofer Medical Research Institute, Brisbane, Australia (LGA, ALP, MG, PJ, JMP, JS, VB, SW, KDR, MSS, GWM, NGM, NKH) · Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK (CDRE, TMK, DJA) · Department of Clinical Genetics, Rigshospitalet, Copenhagen, Denmark (KW, AMG) · Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK (MH, HSn, DTB, JANB) · Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD (JC, KMB) · Departamento de Bioquímica y Biología Molecular, Instituto Universitario de Oncología del Principado de Asturias (IUOPA) Universidad de Oviedo, Oviedo, Spain (VQ, AJR, CLO) · Cancer Genomics Research Laboratory, NCI Frederick, SAIC-Frederick Inc., Frederick MD (XZ, KJ) · Department of Dermatology, Leiden University Medical Centre, Leiden, the Netherlands (RvD, NAG) · Department of Clinical Sciences Lund, Division of Oncology and Pathology, Lund University, Lund, Sweden (HO, CI, ÅB, GJ) · Translational Genomics Institute, Phoenix, AZ (JMT) · University of Sydney at Westmead Millennium Institute, Westmead, Sydney, NSW, Australia (EAH, HSc, GJM) · Melanoma Institute Australia, North Sydney, NSW, Australia (EAH, HSc, GJM). · Pubmed 25505254
2012
  • Cancer Epidemiology and Services Research, Sydney School of Public Health, The University of Sydney, Australia. · Pubmed 22095472
2011
  • Centre for Molecular, Environmental, Genetic and Analytic (MEGA) Epidemiology, Melbourne School of Population Health, University of Melbourne, VIC, Australia. · Pubmed 21472378
  • Center for Molecular, Environmental, Genetic and Analytic Epidemiology, Melbourne School of Population Health, The University of Melbourne, Melbourne, Australia. · Pubmed 21325014
Probable:    Mater Hospital      
2019
  • Department of Epidemiology and Biostatistics, Texas A&M University, College Station, Texas. · Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania, Philadelphia, Pennsylvania. · Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida. · Assistance Publique-Hôpitaux de Paris, Hôpital Cochin et Université Paris Descartes, Paris, France. · Section of Epidemiology and Biostatistics, Leeds Institute of Medical Research at St. James's, University of Leeds, Leeds, United Kingdom. · Gustave Roussy, Université Paris-Saclay, Département de Biopathologie and Institut National de la Santé et de la Recherche Médicale U1186, Villejuif, France. · Department of Internal Medicine and Medical Specialties, University of Genoa and Istituto de Ricovero e Cura a Carattere Scientifico AOU San Martino-IST, Genoa, Italy. · Dermatology Unit, Maurizio Bufalini Hospital, Cesena, Italy. · Melanoma Unit, Dermatology Department, Hospital Clinic Barcelona, Institut de Investigacions Biomediques August Pi Sunyer, Universitat de Barcelona, Barcelona, Spain. · Sydney School of Public Health, The University of Sydney, Sydney, Australia; Melanoma Institute Australia, The University of Sydney, Sydney, Australia. · Institut National de la Santé et de la Recherche Médicale UMR-946, Genetic Variation and Human Disease Unit, Université Paris Diderot, Paris, France. · Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania. · Department of Clinical Genetics, University Hospital of Copenhagen, Copenhagen, Denmark. · Human Genetics Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland. · Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, Brazil. · Department of Dermatology, Leiden University Medical Centre, Leiden, the Netherlands. · Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden. · QIMR Berghofer Medical Research Institute, Herston, Australia. · Institute of Oncology Ljubljana, Zaloska, Ljubljana, Slovenia. · Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Westmead Institute for Medical Research, University of Sydney, Sydney, Australia. · Department of Clinical Sciences, Lund University Hospital Lund, Sweden; Department of Surgery, Lund University Hospital, Lund, Sweden. · Department of Pathology, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, Brazil. · Unidad de Lesiones Pigmentadas, Cátedra de Dermatología, Hospital de Clínicas, Universidad de la República, Montevideo, Uruguay. · Department of Dermatology, Instituto Valenciano de Oncologia, Valencia, Spain. · Latvian Biomedical Research and Study Centre, Riga, Latvia. · Melanoma Unit, Dermatology Department, Hospital Clinic Barcelona, Institut de Investigacions Biomediques August Pi Sunyer, Universitat de Barcelona, Barcelona, Spain; Centro de Investigacion Biomedica en Red de Enfermedades Raras, Instituto de Salud Carlos III, Barcelona, Spain. · Department of Clinical Genetics, Leiden University Medical Center Leiden, the Netherlands. · Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida. Electronic address: · Pubmed 30731170
2016
  • Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, USA. · Department of Biostatistics and Bioinformatics, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA. · Department of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, Pennsylvania, USA. · Assistance Publique-Hôpitaux de Paris, Hôpital Cochin et Université Paris Descartes, Paris, France. · Department of Dermatology, Sheba Medical Center, Tel Hashomer, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. · Department of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands. · Department of Internal Medicine and Medical Specialties, University of Genoa and IRCCS AOU San Martino-IST Genoa, Italy. · Section of Epidemiology and Biostatistics, Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK. · Department of Biopathology and INSERM U1186, Gustave Roussy, Villejuif, France. · Dermatology Unit, Maurizio Bufalini Hospital, Cesena, Italy. · Division of Genetic Epidemiology, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, Utah, USA. · Melanoma Unit, Dermatology Department, Hospital Clinic, IDIBAPS, Barcelona, Spain and CIBER de Enfermedades Raras, Barcelona, Spain. · Sydney School of Public Health, University of Sydney, Sydney, NSW, Australia. · INSERM, UMR-946, Genetic Variation and Human Disease Unit, Université Paris Diderot, Paris, France. · Departments of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA. · The Susanne Levy Gertner Oncogenetics Unit, The Danek Gertner Institute of Human Genetics, Chaim Sheba Medical Center, Tel-Hashomer, Israel. · Department of Clinical Genetics, University Hospital of Copenhagen, Copenhagen, Denmark. · Human Genetics Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA. · Universidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre RS, Brazil. · Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden. · QIMR Berghofer Medical Research Institute, Herston, QLD, Australia. · Institute of Oncology Ljubljana, Zaloska, Ljubljana, Slovenia. · Centre for Cancer Research, Westmead Institute for Medical Research and Melanoma Institute Australia, University of Sydney, NSW, Australia. · Department of Surgery, Lund University Hospital, Lund, Sweden. · Department of Pathology, Escola Paulista de Medicina, UNIFESP, São Paulo, Brazil. · Unidad de Lesiones Pigmentadas, Cátedra de Dermatología, Hospital de Clínicas, Universidad de la República, Montevideo, Uruguay. · Oregon Health Sciences University School of Medicine, Department of Dermatology, Portland, Oregon, USA. · Department of Dermatology, Instituto Valenciano de Oncologia, Valencia, Spain. · Latvian Biomedical Research and Study Centre, Riga, Latvia. · Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, USA. Electronic address: · Pubmed 26827760
2014
  • Section of Epidemiology and Biostatistics, Leeds Institute of Cancer and Pathology (LICAP), University of Leeds, Leeds, UK. · Cancer Epidemiology and Services Research (CESR), Sydney School of Public Health, Sydney Medical School, The University of Sydney, Sydney, Australia. · Dermatology Department and Biochemistry and Molecular Genetics Department, Melanoma Unit, Hospital Clinic, Instituto de Investigaciones Biomédicas August Pi I Sunyer (IDIBAPS), Barcelona, Spain ; Centro Investigación Biomédica en Enfermedades Raras (CIBERER), Instituto de Salud Carlos III (ISCIII), Barcelona, Spain. · Westmead Institute for Cancer Research and Melanoma Institute, Australia, University of Sydney at Westmead Millennium Institute, Sydney, Australia. · Viertel Centre for Research in Cancer Control, The Cancer Council Queensland, Spring Hill, Brisbane, Australia. · Centre for Epidemiology & Biostatistics, School of Population Health, University of Melbourne, Melbourne, Australia ; Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Australia. · Centre for Epidemiology & Biostatistics, School of Population Health, University of Melbourne, Melbourne, Australia. · Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL USA. · Genomics Facility, Leeds Cancer Research UK Centre, University of Leeds, Leeds, UK. · Dermatology Department and Biochemistry and Molecular Genetics Department, Melanoma Unit, Hospital Clinic, Instituto de Investigaciones Biomédicas August Pi I Sunyer (IDIBAPS), Barcelona, Spain. · Medicina Laboral, Lafarge Cementos y Finanzauto, S.A., Barcelona, Spain. · Pubmed 25780468
2015
  • Affiliations of authors: QIMR Berghofer Medical Research Institute, Brisbane, Australia (LGA, ALP, MG, PJ, JMP, JS, VB, SW, KDR, MSS, GWM, NGM, NKH) · Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK (CDRE, TMK, DJA) · Department of Clinical Genetics, Rigshospitalet, Copenhagen, Denmark (KW, AMG) · Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK (MH, HSn, DTB, JANB) · Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD (JC, KMB) · Departamento de Bioquímica y Biología Molecular, Instituto Universitario de Oncología del Principado de Asturias (IUOPA) Universidad de Oviedo, Oviedo, Spain (VQ, AJR, CLO) · Cancer Genomics Research Laboratory, NCI Frederick, SAIC-Frederick Inc., Frederick MD (XZ, KJ) · Department of Dermatology, Leiden University Medical Centre, Leiden, the Netherlands (RvD, NAG) · Department of Clinical Sciences Lund, Division of Oncology and Pathology, Lund University, Lund, Sweden (HO, CI, ÅB, GJ) · Translational Genomics Institute, Phoenix, AZ (JMT) · University of Sydney at Westmead Millennium Institute, Westmead, Sydney, NSW, Australia (EAH, HSc, GJM) · Melanoma Institute Australia, North Sydney, NSW, Australia (EAH, HSc, GJM). · Pubmed 25505254
Probable:    Westmead Hospital      
2014
  • Section of Epidemiology and Biostatistics, Leeds Institute of Cancer and Pathology (LICAP), University of Leeds, Leeds, UK. · Cancer Epidemiology and Services Research (CESR), Sydney School of Public Health, Sydney Medical School, The University of Sydney, Sydney, Australia. · Dermatology Department and Biochemistry and Molecular Genetics Department, Melanoma Unit, Hospital Clinic, Instituto de Investigaciones Biomédicas August Pi I Sunyer (IDIBAPS), Barcelona, Spain ; Centro Investigación Biomédica en Enfermedades Raras (CIBERER), Instituto de Salud Carlos III (ISCIII), Barcelona, Spain. · Westmead Institute for Cancer Research and Melanoma Institute, Australia, University of Sydney at Westmead Millennium Institute, Sydney, Australia. · Viertel Centre for Research in Cancer Control, The Cancer Council Queensland, Spring Hill, Brisbane, Australia. · Centre for Epidemiology & Biostatistics, School of Population Health, University of Melbourne, Melbourne, Australia ; Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Australia. · Centre for Epidemiology & Biostatistics, School of Population Health, University of Melbourne, Melbourne, Australia. · Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL USA. · Genomics Facility, Leeds Cancer Research UK Centre, University of Leeds, Leeds, UK. · Dermatology Department and Biochemistry and Molecular Genetics Department, Melanoma Unit, Hospital Clinic, Instituto de Investigaciones Biomédicas August Pi I Sunyer (IDIBAPS), Barcelona, Spain. · Medicina Laboral, Lafarge Cementos y Finanzauto, S.A., Barcelona, Spain. · Pubmed 25780468
  • Discipline of Dermatology, University of Sydney at the Sydney Cancer Centre, Sydney, New South Wales, Australia2Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia3Sydney Melanoma Diagnostic Centre, Sydney Cancer Centre, Sydney, New South. · Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia3Sydney Melanoma Diagnostic Centre, Sydney Cancer Centre, Sydney, New South Wales, Australia. · National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney, New South Wales, Australia. · Raudonikis Database Services, Mount Colah, New South Wales, Australia. · University of Sydney at the Westmead Millennium Institute, Westmead, New South Wales, Australia9Melanoma Institute Australia, Westmead, New South Wales, Australia. · Pubmed 24964862
2015
  • Affiliations of authors: QIMR Berghofer Medical Research Institute, Brisbane, Australia (LGA, ALP, MG, PJ, JMP, JS, VB, SW, KDR, MSS, GWM, NGM, NKH) · Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK (CDRE, TMK, DJA) · Department of Clinical Genetics, Rigshospitalet, Copenhagen, Denmark (KW, AMG) · Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK (MH, HSn, DTB, JANB) · Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD (JC, KMB) · Departamento de Bioquímica y Biología Molecular, Instituto Universitario de Oncología del Principado de Asturias (IUOPA) Universidad de Oviedo, Oviedo, Spain (VQ, AJR, CLO) · Cancer Genomics Research Laboratory, NCI Frederick, SAIC-Frederick Inc., Frederick MD (XZ, KJ) · Department of Dermatology, Leiden University Medical Centre, Leiden, the Netherlands (RvD, NAG) · Department of Clinical Sciences Lund, Division of Oncology and Pathology, Lund University, Lund, Sweden (HO, CI, ÅB, GJ) · Translational Genomics Institute, Phoenix, AZ (JMT) · University of Sydney at Westmead Millennium Institute, Westmead, Sydney, NSW, Australia (EAH, HSc, GJM) · Melanoma Institute Australia, North Sydney, NSW, Australia (EAH, HSc, GJM). · Pubmed 25505254
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 13 total) written by Helen Schmid about Melanoma:

  • Estimating CDKN2A mutation carrier probability among global familial melanoma cases using GenoMELPREDICT. 2019
  • Sunscreen Use and Melanoma Risk Among Young Australian Adults. 2018
  • Phenotypic and Histopathological Tumor Characteristics According to CDKN2A Mutation Status among Affected Members of Melanoma Families. 2016
  • Nonsense mutations in the shelterin complex genes ACD and TERF2IP in familial melanoma. 2015
  • Prevalence and predictors of germline CDKN2A mutations for melanoma cases from Australia, Spain and the United Kingdom. 2014
  • Detection of primary melanoma in individuals at extreme high risk: a prospective 5-year follow-up study. 2014
  • MC1R genotype as a predictor of early-onset melanoma, compared with self-reported and physician-measured traditional risk factors: an Australian case-control-family study. 2013
  • MC1R genotypes and risk of melanoma before age 40 years: a population-based case-control-family study. 2012
  • A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma. 2011
  • Genome-wide association study identifies a new melanoma susceptibility locus at 1q21.3. 2011
Show List of Full Article Records
Google Searches

Learn more about Helen Schmid using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
University of Sydney
Mater Hospital
Westmead Hospital
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
University of Sydney
2019
  • Department of Epidemiology and Biostatistics, Texas A&M University, College Station, Texas. · Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania, Philadelphia, Pennsylvania. · Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida. · Assistance Publique-Hôpitaux de Paris, Hôpital Cochin et Université Paris Descartes, Paris, France. · Section of Epidemiology and Biostatistics, Leeds Institute of Medical Research at St. James's, University of Leeds, Leeds, United Kingdom. · Gustave Roussy, Université Paris-Saclay, Département de Biopathologie and Institut National de la Santé et de la Recherche Médicale U1186, Villejuif, France. · Department of Internal Medicine and Medical Specialties, University of Genoa and Istituto de Ricovero e Cura a Carattere Scientifico AOU San Martino-IST, Genoa, Italy. · Dermatology Unit, Maurizio Bufalini Hospital, Cesena, Italy. · Melanoma Unit, Dermatology Department, Hospital Clinic Barcelona, Institut de Investigacions Biomediques August Pi Sunyer, Universitat de Barcelona, Barcelona, Spain. · Sydney School of Public Health, The University of Sydney, Sydney, Australia; Melanoma Institute Australia, The University of Sydney, Sydney, Australia. · Institut National de la Santé et de la Recherche Médicale UMR-946, Genetic Variation and Human Disease Unit, Université Paris Diderot, Paris, France. · Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania. · Department of Clinical Genetics, University Hospital of Copenhagen, Copenhagen, Denmark. · Human Genetics Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland. · Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, Brazil. · Department of Dermatology, Leiden University Medical Centre, Leiden, the Netherlands. · Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden. · QIMR Berghofer Medical Research Institute, Herston, Australia. · Institute of Oncology Ljubljana, Zaloska, Ljubljana, Slovenia. · Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Westmead Institute for Medical Research, University of Sydney, Sydney, Australia. · Department of Clinical Sciences, Lund University Hospital Lund, Sweden; Department of Surgery, Lund University Hospital, Lund, Sweden. · Department of Pathology, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, Brazil. · Unidad de Lesiones Pigmentadas, Cátedra de Dermatología, Hospital de Clínicas, Universidad de la República, Montevideo, Uruguay. · Department of Dermatology, Instituto Valenciano de Oncologia, Valencia, Spain. · Latvian Biomedical Research and Study Centre, Riga, Latvia. · Melanoma Unit, Dermatology Department, Hospital Clinic Barcelona, Institut de Investigacions Biomediques August Pi Sunyer, Universitat de Barcelona, Barcelona, Spain; Centro de Investigacion Biomedica en Red de Enfermedades Raras, Instituto de Salud Carlos III, Barcelona, Spain. · Department of Clinical Genetics, Leiden University Medical Center Leiden, the Netherlands. · Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida. Electronic address: · Pubmed 30731170
2018
  • Cancer Epidemiology and Prevention Research, Sydney School of Public Health, The University of Sydney, Camperdown, New South Wales, Australia. · Melanoma Institute Australia, Sydney, New South Wales, Australia. · Now with The Kirby Institute, University of New South Wales, Sydney, Australia. · Faculty of Medicine and Health, Sydney School of Public Health, The University of Sydney, Sydney, New South Wales, Australia. · Melanoma Research Group, Centre for Cancer Research, The Westmead Institute for Medical Research, The University of Sydney, Sydney, New South Wales, Australia. · The School of Population Health, The University of Western Australia, Perth, Australia. · Viertel Cancer Research Centre, Cancer Council Queensland, Brisbane, Australia. · Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia. · Cancer Epidemiology and Intelligence Division, Cancer Council Victoria, Melbourne, Australia. · Pubmed 30027280
2016
  • Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, USA. · Department of Biostatistics and Bioinformatics, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA. · Department of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, Pennsylvania, USA. · Assistance Publique-Hôpitaux de Paris, Hôpital Cochin et Université Paris Descartes, Paris, France. · Department of Dermatology, Sheba Medical Center, Tel Hashomer, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. · Department of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands. · Department of Internal Medicine and Medical Specialties, University of Genoa and IRCCS AOU San Martino-IST Genoa, Italy. · Section of Epidemiology and Biostatistics, Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK. · Department of Biopathology and INSERM U1186, Gustave Roussy, Villejuif, France. · Dermatology Unit, Maurizio Bufalini Hospital, Cesena, Italy. · Division of Genetic Epidemiology, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, Utah, USA. · Melanoma Unit, Dermatology Department, Hospital Clinic, IDIBAPS, Barcelona, Spain and CIBER de Enfermedades Raras, Barcelona, Spain. · Sydney School of Public Health, University of Sydney, Sydney, NSW, Australia. · INSERM, UMR-946, Genetic Variation and Human Disease Unit, Université Paris Diderot, Paris, France. · Departments of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA. · The Susanne Levy Gertner Oncogenetics Unit, The Danek Gertner Institute of Human Genetics, Chaim Sheba Medical Center, Tel-Hashomer, Israel. · Department of Clinical Genetics, University Hospital of Copenhagen, Copenhagen, Denmark. · Human Genetics Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA. · Universidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre RS, Brazil. · Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden. · QIMR Berghofer Medical Research Institute, Herston, QLD, Australia. · Institute of Oncology Ljubljana, Zaloska, Ljubljana, Slovenia. · Centre for Cancer Research, Westmead Institute for Medical Research and Melanoma Institute Australia, University of Sydney, NSW, Australia. · Department of Surgery, Lund University Hospital, Lund, Sweden. · Department of Pathology, Escola Paulista de Medicina, UNIFESP, São Paulo, Brazil. · Unidad de Lesiones Pigmentadas, Cátedra de Dermatología, Hospital de Clínicas, Universidad de la República, Montevideo, Uruguay. · Oregon Health Sciences University School of Medicine, Department of Dermatology, Portland, Oregon, USA. · Department of Dermatology, Instituto Valenciano de Oncologia, Valencia, Spain. · Latvian Biomedical Research and Study Centre, Riga, Latvia. · Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, USA. Electronic address: · Pubmed 26827760
2014
  • Section of Epidemiology and Biostatistics, Leeds Institute of Cancer and Pathology (LICAP), University of Leeds, Leeds, UK. · Cancer Epidemiology and Services Research (CESR), Sydney School of Public Health, Sydney Medical School, The University of Sydney, Sydney, Australia. · Dermatology Department and Biochemistry and Molecular Genetics Department, Melanoma Unit, Hospital Clinic, Instituto de Investigaciones Biomédicas August Pi I Sunyer (IDIBAPS), Barcelona, Spain ; Centro Investigación Biomédica en Enfermedades Raras (CIBERER), Instituto de Salud Carlos III (ISCIII), Barcelona, Spain. · Westmead Institute for Cancer Research and Melanoma Institute, Australia, University of Sydney at Westmead Millennium Institute, Sydney, Australia. · Viertel Centre for Research in Cancer Control, The Cancer Council Queensland, Spring Hill, Brisbane, Australia. · Centre for Epidemiology & Biostatistics, School of Population Health, University of Melbourne, Melbourne, Australia ; Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Australia. · Centre for Epidemiology & Biostatistics, School of Population Health, University of Melbourne, Melbourne, Australia. · Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL USA. · Genomics Facility, Leeds Cancer Research UK Centre, University of Leeds, Leeds, UK. · Dermatology Department and Biochemistry and Molecular Genetics Department, Melanoma Unit, Hospital Clinic, Instituto de Investigaciones Biomédicas August Pi I Sunyer (IDIBAPS), Barcelona, Spain. · Medicina Laboral, Lafarge Cementos y Finanzauto, S.A., Barcelona, Spain. · Pubmed 25780468
  • Discipline of Dermatology, University of Sydney at the Sydney Cancer Centre, Sydney, New South Wales, Australia2Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia3Sydney Melanoma Diagnostic Centre, Sydney Cancer Centre, Sydney, New South. · Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia3Sydney Melanoma Diagnostic Centre, Sydney Cancer Centre, Sydney, New South Wales, Australia. · National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney, New South Wales, Australia. · Raudonikis Database Services, Mount Colah, New South Wales, Australia. · University of Sydney at the Westmead Millennium Institute, Westmead, New South Wales, Australia9Melanoma Institute Australia, Westmead, New South Wales, Australia. · Pubmed 24964862
2015
  • Affiliations of authors: QIMR Berghofer Medical Research Institute, Brisbane, Australia (LGA, ALP, MG, PJ, JMP, JS, VB, SW, KDR, MSS, GWM, NGM, NKH) · Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK (CDRE, TMK, DJA) · Department of Clinical Genetics, Rigshospitalet, Copenhagen, Denmark (KW, AMG) · Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK (MH, HSn, DTB, JANB) · Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD (JC, KMB) · Departamento de Bioquímica y Biología Molecular, Instituto Universitario de Oncología del Principado de Asturias (IUOPA) Universidad de Oviedo, Oviedo, Spain (VQ, AJR, CLO) · Cancer Genomics Research Laboratory, NCI Frederick, SAIC-Frederick Inc., Frederick MD (XZ, KJ) · Department of Dermatology, Leiden University Medical Centre, Leiden, the Netherlands (RvD, NAG) · Department of Clinical Sciences Lund, Division of Oncology and Pathology, Lund University, Lund, Sweden (HO, CI, ÅB, GJ) · Translational Genomics Institute, Phoenix, AZ (JMT) · University of Sydney at Westmead Millennium Institute, Westmead, Sydney, NSW, Australia (EAH, HSc, GJM) · Melanoma Institute Australia, North Sydney, NSW, Australia (EAH, HSc, GJM). · Pubmed 25505254
2012
  • Cancer Epidemiology and Services Research, Sydney School of Public Health, The University of Sydney, Australia. · Pubmed 22095472
2011
  • Centre for Molecular, Environmental, Genetic and Analytic (MEGA) Epidemiology, Melbourne School of Population Health, University of Melbourne, VIC, Australia. · Pubmed 21472378
  • Center for Molecular, Environmental, Genetic and Analytic Epidemiology, Melbourne School of Population Health, The University of Melbourne, Melbourne, Australia. · Pubmed 21325014
Mater Hospital
2019
  • Department of Epidemiology and Biostatistics, Texas A&M University, College Station, Texas. · Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania, Philadelphia, Pennsylvania. · Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida. · Assistance Publique-Hôpitaux de Paris, Hôpital Cochin et Université Paris Descartes, Paris, France. · Section of Epidemiology and Biostatistics, Leeds Institute of Medical Research at St. James's, University of Leeds, Leeds, United Kingdom. · Gustave Roussy, Université Paris-Saclay, Département de Biopathologie and Institut National de la Santé et de la Recherche Médicale U1186, Villejuif, France. · Department of Internal Medicine and Medical Specialties, University of Genoa and Istituto de Ricovero e Cura a Carattere Scientifico AOU San Martino-IST, Genoa, Italy. · Dermatology Unit, Maurizio Bufalini Hospital, Cesena, Italy. · Melanoma Unit, Dermatology Department, Hospital Clinic Barcelona, Institut de Investigacions Biomediques August Pi Sunyer, Universitat de Barcelona, Barcelona, Spain. · Sydney School of Public Health, The University of Sydney, Sydney, Australia; Melanoma Institute Australia, The University of Sydney, Sydney, Australia. · Institut National de la Santé et de la Recherche Médicale UMR-946, Genetic Variation and Human Disease Unit, Université Paris Diderot, Paris, France. · Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania. · Department of Clinical Genetics, University Hospital of Copenhagen, Copenhagen, Denmark. · Human Genetics Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland. · Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, Brazil. · Department of Dermatology, Leiden University Medical Centre, Leiden, the Netherlands. · Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden. · QIMR Berghofer Medical Research Institute, Herston, Australia. · Institute of Oncology Ljubljana, Zaloska, Ljubljana, Slovenia. · Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Westmead Institute for Medical Research, University of Sydney, Sydney, Australia. · Department of Clinical Sciences, Lund University Hospital Lund, Sweden; Department of Surgery, Lund University Hospital, Lund, Sweden. · Department of Pathology, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, Brazil. · Unidad de Lesiones Pigmentadas, Cátedra de Dermatología, Hospital de Clínicas, Universidad de la República, Montevideo, Uruguay. · Department of Dermatology, Instituto Valenciano de Oncologia, Valencia, Spain. · Latvian Biomedical Research and Study Centre, Riga, Latvia. · Melanoma Unit, Dermatology Department, Hospital Clinic Barcelona, Institut de Investigacions Biomediques August Pi Sunyer, Universitat de Barcelona, Barcelona, Spain; Centro de Investigacion Biomedica en Red de Enfermedades Raras, Instituto de Salud Carlos III, Barcelona, Spain. · Department of Clinical Genetics, Leiden University Medical Center Leiden, the Netherlands. · Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida. Electronic address: · Pubmed 30731170
2016
  • Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, USA. · Department of Biostatistics and Bioinformatics, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA. · Department of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, Pennsylvania, USA. · Assistance Publique-Hôpitaux de Paris, Hôpital Cochin et Université Paris Descartes, Paris, France. · Department of Dermatology, Sheba Medical Center, Tel Hashomer, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. · Department of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands. · Department of Internal Medicine and Medical Specialties, University of Genoa and IRCCS AOU San Martino-IST Genoa, Italy. · Section of Epidemiology and Biostatistics, Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK. · Department of Biopathology and INSERM U1186, Gustave Roussy, Villejuif, France. · Dermatology Unit, Maurizio Bufalini Hospital, Cesena, Italy. · Division of Genetic Epidemiology, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, Utah, USA. · Melanoma Unit, Dermatology Department, Hospital Clinic, IDIBAPS, Barcelona, Spain and CIBER de Enfermedades Raras, Barcelona, Spain. · Sydney School of Public Health, University of Sydney, Sydney, NSW, Australia. · INSERM, UMR-946, Genetic Variation and Human Disease Unit, Université Paris Diderot, Paris, France. · Departments of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA. · The Susanne Levy Gertner Oncogenetics Unit, The Danek Gertner Institute of Human Genetics, Chaim Sheba Medical Center, Tel-Hashomer, Israel. · Department of Clinical Genetics, University Hospital of Copenhagen, Copenhagen, Denmark. · Human Genetics Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA. · Universidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre RS, Brazil. · Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden. · QIMR Berghofer Medical Research Institute, Herston, QLD, Australia. · Institute of Oncology Ljubljana, Zaloska, Ljubljana, Slovenia. · Centre for Cancer Research, Westmead Institute for Medical Research and Melanoma Institute Australia, University of Sydney, NSW, Australia. · Department of Surgery, Lund University Hospital, Lund, Sweden. · Department of Pathology, Escola Paulista de Medicina, UNIFESP, São Paulo, Brazil. · Unidad de Lesiones Pigmentadas, Cátedra de Dermatología, Hospital de Clínicas, Universidad de la República, Montevideo, Uruguay. · Oregon Health Sciences University School of Medicine, Department of Dermatology, Portland, Oregon, USA. · Department of Dermatology, Instituto Valenciano de Oncologia, Valencia, Spain. · Latvian Biomedical Research and Study Centre, Riga, Latvia. · Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, USA. Electronic address: · Pubmed 26827760
2014
  • Section of Epidemiology and Biostatistics, Leeds Institute of Cancer and Pathology (LICAP), University of Leeds, Leeds, UK. · Cancer Epidemiology and Services Research (CESR), Sydney School of Public Health, Sydney Medical School, The University of Sydney, Sydney, Australia. · Dermatology Department and Biochemistry and Molecular Genetics Department, Melanoma Unit, Hospital Clinic, Instituto de Investigaciones Biomédicas August Pi I Sunyer (IDIBAPS), Barcelona, Spain ; Centro Investigación Biomédica en Enfermedades Raras (CIBERER), Instituto de Salud Carlos III (ISCIII), Barcelona, Spain. · Westmead Institute for Cancer Research and Melanoma Institute, Australia, University of Sydney at Westmead Millennium Institute, Sydney, Australia. · Viertel Centre for Research in Cancer Control, The Cancer Council Queensland, Spring Hill, Brisbane, Australia. · Centre for Epidemiology & Biostatistics, School of Population Health, University of Melbourne, Melbourne, Australia ; Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Australia. · Centre for Epidemiology & Biostatistics, School of Population Health, University of Melbourne, Melbourne, Australia. · Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL USA. · Genomics Facility, Leeds Cancer Research UK Centre, University of Leeds, Leeds, UK. · Dermatology Department and Biochemistry and Molecular Genetics Department, Melanoma Unit, Hospital Clinic, Instituto de Investigaciones Biomédicas August Pi I Sunyer (IDIBAPS), Barcelona, Spain. · Medicina Laboral, Lafarge Cementos y Finanzauto, S.A., Barcelona, Spain. · Pubmed 25780468
2015
  • Affiliations of authors: QIMR Berghofer Medical Research Institute, Brisbane, Australia (LGA, ALP, MG, PJ, JMP, JS, VB, SW, KDR, MSS, GWM, NGM, NKH) · Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK (CDRE, TMK, DJA) · Department of Clinical Genetics, Rigshospitalet, Copenhagen, Denmark (KW, AMG) · Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK (MH, HSn, DTB, JANB) · Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD (JC, KMB) · Departamento de Bioquímica y Biología Molecular, Instituto Universitario de Oncología del Principado de Asturias (IUOPA) Universidad de Oviedo, Oviedo, Spain (VQ, AJR, CLO) · Cancer Genomics Research Laboratory, NCI Frederick, SAIC-Frederick Inc., Frederick MD (XZ, KJ) · Department of Dermatology, Leiden University Medical Centre, Leiden, the Netherlands (RvD, NAG) · Department of Clinical Sciences Lund, Division of Oncology and Pathology, Lund University, Lund, Sweden (HO, CI, ÅB, GJ) · Translational Genomics Institute, Phoenix, AZ (JMT) · University of Sydney at Westmead Millennium Institute, Westmead, Sydney, NSW, Australia (EAH, HSc, GJM) · Melanoma Institute Australia, North Sydney, NSW, Australia (EAH, HSc, GJM). · Pubmed 25505254
Westmead Hospital
2014
  • Section of Epidemiology and Biostatistics, Leeds Institute of Cancer and Pathology (LICAP), University of Leeds, Leeds, UK. · Cancer Epidemiology and Services Research (CESR), Sydney School of Public Health, Sydney Medical School, The University of Sydney, Sydney, Australia. · Dermatology Department and Biochemistry and Molecular Genetics Department, Melanoma Unit, Hospital Clinic, Instituto de Investigaciones Biomédicas August Pi I Sunyer (IDIBAPS), Barcelona, Spain ; Centro Investigación Biomédica en Enfermedades Raras (CIBERER), Instituto de Salud Carlos III (ISCIII), Barcelona, Spain. · Westmead Institute for Cancer Research and Melanoma Institute, Australia, University of Sydney at Westmead Millennium Institute, Sydney, Australia. · Viertel Centre for Research in Cancer Control, The Cancer Council Queensland, Spring Hill, Brisbane, Australia. · Centre for Epidemiology & Biostatistics, School of Population Health, University of Melbourne, Melbourne, Australia ; Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Australia. · Centre for Epidemiology & Biostatistics, School of Population Health, University of Melbourne, Melbourne, Australia. · Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL USA. · Genomics Facility, Leeds Cancer Research UK Centre, University of Leeds, Leeds, UK. · Dermatology Department and Biochemistry and Molecular Genetics Department, Melanoma Unit, Hospital Clinic, Instituto de Investigaciones Biomédicas August Pi I Sunyer (IDIBAPS), Barcelona, Spain. · Medicina Laboral, Lafarge Cementos y Finanzauto, S.A., Barcelona, Spain. · Pubmed 25780468
  • Discipline of Dermatology, University of Sydney at the Sydney Cancer Centre, Sydney, New South Wales, Australia2Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia3Sydney Melanoma Diagnostic Centre, Sydney Cancer Centre, Sydney, New South. · Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia3Sydney Melanoma Diagnostic Centre, Sydney Cancer Centre, Sydney, New South Wales, Australia. · National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney, New South Wales, Australia. · Raudonikis Database Services, Mount Colah, New South Wales, Australia. · University of Sydney at the Westmead Millennium Institute, Westmead, New South Wales, Australia9Melanoma Institute Australia, Westmead, New South Wales, Australia. · Pubmed 24964862
2015
  • Affiliations of authors: QIMR Berghofer Medical Research Institute, Brisbane, Australia (LGA, ALP, MG, PJ, JMP, JS, VB, SW, KDR, MSS, GWM, NGM, NKH) · Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK (CDRE, TMK, DJA) · Department of Clinical Genetics, Rigshospitalet, Copenhagen, Denmark (KW, AMG) · Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK (MH, HSn, DTB, JANB) · Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD (JC, KMB) · Departamento de Bioquímica y Biología Molecular, Instituto Universitario de Oncología del Principado de Asturias (IUOPA) Universidad de Oviedo, Oviedo, Spain (VQ, AJR, CLO) · Cancer Genomics Research Laboratory, NCI Frederick, SAIC-Frederick Inc., Frederick MD (XZ, KJ) · Department of Dermatology, Leiden University Medical Centre, Leiden, the Netherlands (RvD, NAG) · Department of Clinical Sciences Lund, Division of Oncology and Pathology, Lund University, Lund, Sweden (HO, CI, ÅB, GJ) · Translational Genomics Institute, Phoenix, AZ (JMT) · University of Sydney at Westmead Millennium Institute, Westmead, Sydney, NSW, Australia (EAH, HSc, GJM) · Melanoma Institute Australia, North Sydney, NSW, Australia (EAH, HSc, GJM). · Pubmed 25505254
12 Other Locations Show
Yearly article counts 01101121150
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.